1.
KŁUSEK, Magdalena, CHAWRYLAK, Katarzyna, KUSZNERUK, Julia, KUBAS, Maria and KRZEMIŃSKA, Katarzyna. Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review. Quality in Sport. Online. 25 July 2024. Vol. 18, p. 53252. [Accessed 26 July 2024]. DOI 10.12775/QS.2024.18.53252.